Our Pricing

Orlistat Online Prescription UK - Not Same as Ozempic

Published on: June 03, 2026

Searching for an orlistat online prescription UK service? Many patients confuse orlistat with Ozempic (semaglutide), but these medications work through entirely different mechanisms and suit different clinical profiles. At Cured Pharmacy, our UK-registered prescribers assess your suitability for orlistat, Wegovy, or other licensed weight loss treatments during a free consultation under three minutes.

How Orlistat Works Compared to Ozempic and Semaglutide

Orlistat is a lipase inhibitor that blocks approximately 25% of dietary fat absorption in your digestive system [1]. It works locally in your gut without entering your bloodstream, preventing fat digestion rather than altering appetite hormones. This mechanism produces modest weight loss—typically 5-10% of body weight over 12 months when combined with a reduced-calorie diet [1].

Ozempic (semaglutide) and Wegovy (also semaglutide, but licensed specifically for weight management) are GLP-1 receptor agonists that work systemically by mimicking a natural gut hormone [2]. They slow gastric emptying, reduce appetite centrally in the brain, and improve insulin sensitivity. In the STEP trials, semaglutide 2.4mg produced average weight loss of 15% over 68 weeks—significantly higher than orlistat's typical outcomes [2][3].

The fundamental difference: orlistat prevents calorie absorption mechanically, whilst semaglutide-based treatments alter your body's hormonal signals for hunger and satiety. Neither medication is 'better' universally—your suitability depends on your BMI, medical history, tolerance for gastrointestinal side effects, and whether you're comfortable with weekly injections.

Who Is Suitable for Orlistat Online Prescription UK

UK prescribers assess orlistat suitability based on NICE guidance: adults with BMI ≥30 kg/m², or BMI ≥28 kg/m² with weight-related comorbidities such as type 2 diabetes or hypertension [4]. You must demonstrate commitment to dietary changes, as orlistat only works when combined with a reduced-fat diet (ideally under 30% of daily calories from fat).

Orlistat may be preferred over injectable GLP-1 treatments if you have needle phobia, prefer oral medication, or have contraindications to semaglutide such as personal or family history of medullary thyroid carcinoma. It's also suitable for patients seeking a non-systemic option with a well-established 25-year safety profile in the UK [1].

However, orlistat is not appropriate if you have chronic malabsorption syndrome, cholestasis, or are taking ciclosporin. Your UK prescriber will review your full medication list during consultation, as orlistat can reduce absorption of fat-soluble vitamins and certain medications including levothyroxine and warfarin [4].

Clinical Assessment Process at Cured Pharmacy

Our online consultation takes under three minutes and covers your weight history, current medications, dietary habits, and weight loss goals. Superintendent pharmacist Tarun Kumar (GPhC 2233073) and our UK clinical team review every assessment personally. If orlistat is unsuitable but you meet criteria for semaglutide-based treatments like Wegovy, we'll recommend the most appropriate licensed option with transparent pricing shown upfront before any prescription is issued.

Orlistat Side Effects vs Semaglutide Side Effects

Orlistat's side effects are predominantly gastrointestinal and directly related to its mechanism: oily stools, faecal urgency, flatulence with discharge, and increased bowel frequency [1]. These effects worsen with high-fat meals and typically improve as patients adjust their diet. The side effects are not dangerous but can significantly impact quality of life if dietary fat intake isn't controlled.

Semaglutide's side effects are different: nausea (reported in 44% of STEP trial participants initially), vomiting, diarrhoea, constipation, and abdominal pain [2][3]. These are systemic effects related to slowed gastric emptying and usually diminish after 4-8 weeks as your body adapts. Rare but serious risks include pancreatitis and gallbladder disease, which require immediate medical attention.

In clinical practice, orlistat's tolerability depends entirely on dietary adherence—patients who maintain low-fat intake experience minimal side effects. Semaglutide's nausea occurs regardless of diet but is dose-dependent, which is why UK prescribers start at lower doses and titrate gradually over 16-20 weeks.

Managing Side Effects Effectively

For orlistat, distribute your daily fat intake evenly across three main meals (approximately 15g fat per meal) and avoid high-fat snacks entirely. Taking a multivitamin containing vitamins A, D, E, and K at bedtime (at least 2 hours after orlistat) prevents deficiency. For semaglutide, eat smaller portions, avoid lying down immediately after meals, and stay well-hydrated. Our clinical team provides detailed side effect management guidance with every prescription issued.

Orlistat vs Ozempic: Efficacy and Clinical Trial Data

In the landmark XENDOS trial, orlistat 120mg three times daily combined with lifestyle intervention produced average weight loss of 10.6kg over 12 months, compared to 6.2kg with placebo and lifestyle changes alone [1]. However, weight regain is common after discontinuation if dietary habits revert.

The STEP-1 trial demonstrated semaglutide 2.4mg (Wegovy) produced average weight loss of 14.9% of initial body weight over 68 weeks, with 50% of participants losing ≥15% and 32% losing ≥20% [2]. The STEP-5 trial extended follow-up to 104 weeks, showing sustained weight loss of 15.2% at two years [3].

Head-to-head comparisons don't exist, but indirect evidence suggests semaglutide produces approximately 1.5-2 times greater weight loss than orlistat in typical clinical use. Orlistat requires strict dietary adherence to achieve even modest results, whilst semaglutide's appetite suppression makes calorie restriction easier to maintain. For patients with BMI >35 kg/m² or those who haven't succeeded with orlistat previously, UK prescribers typically recommend considering GLP-1 treatments first-line, subject to suitability assessment.

Cost and Accessibility: Orlistat Online Prescription UK Services

Orlistat is available both over-the-counter (as Alli 60mg) and on prescription (as Xenical 120mg or generic orlistat 120mg). The prescription-strength 120mg dose is more effective than the 60mg OTC version and requires clinical assessment by a UK prescriber.

At Cured Pharmacy, we offer transparent upfront pricing for all weight loss treatments, with costs displayed before you complete your consultation. Our pricing includes the medication, UK prescriber review, and discreet delivery—no hidden fees. We guarantee the lowest prices in the UK for licensed weight loss medications.

Wegovy (semaglutide) starts from £79.00 at Cured Pharmacy, representing exceptional value for a treatment with significantly higher efficacy than orlistat in clinical trials. Whilst the upfront cost is higher than orlistat, the greater weight loss outcomes and once-weekly dosing (versus three-times-daily for orlistat) make it cost-effective for many patients. Your prescriber will discuss all suitable options during your free consultation, allowing you to make an informed choice based on efficacy, convenience, and budget.

Why Choose Cured Pharmacy for Weight Loss Treatment

We're a fully registered UK pharmacy (GPhC 9012511) offering genuine UK-licensed medications only. Every prescription is reviewed by our UK clinical team, with superintendent oversight by Tarun Kumar (GPhC 2233073). We provide 100% discreet packaging, next-day delivery options, and transparent pricing with no surprise fees. Our online consultation takes under three minutes, and you'll receive a prescriber decision within hours, not days. If you're seeking an orlistat online prescription UK service or want to explore higher-efficacy alternatives like Wegovy, start your free assessment today.

Alternative Weight Loss Treatments Available at Cured Pharmacy

Beyond orlistat and semaglutide, several other licensed weight loss medications are available through UK prescription. Each works through a distinct mechanism and suits different patient profiles.

Wegovy (semaglutide 2.4mg) is the most effective single-agent weight loss medication currently licensed in the UK, producing average weight loss of 15% in clinical trials. It's administered as a once-weekly subcutaneous injection and is suitable for adults with BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities. Wegovy is the same active ingredient as Ozempic but licensed specifically for chronic weight management at a higher dose [2][3].

Your UK prescriber will recommend the most appropriate treatment based on your individual clinical profile, previous weight loss attempts, comorbidities, and personal preferences regarding route of administration. All prescription weight loss medications require ongoing clinical monitoring and work best when combined with dietary modification and increased physical activity. At Cured Pharmacy, we provide comprehensive patient information leaflets and ongoing support throughout your treatment journey.

Scientific References

1. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to lifestyle modifications including diet and exercise. Orlistat, Wegovy, and other weight loss medications are intended for use as part of a comprehensive weight management programme under medical supervision.